Earn CME for related activities: https://hmpeducation.com/
In this webcast from the 'MRD in Hematologic Malignancies: Testing Considerations and Challenges' symposium, Dr. Gail J. Roboz discusses the role of minimal residual disease (MRD) testing in the treatment of acute myeloid leukemia (AML).